Nuvo Pharmaceuticals Inc (MRVFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,194 | -5,579 | 34,960 | -10,080 | N/A |
| Depreciation Amortization | 176 | 245 | 640 | 1,290 | N/A |
| Accounts receivable | 2,096 | -1,618 | N/A | N/A | N/A |
| Other Working Capital | -1,883 | -2,618 | 0 | 650 | N/A |
| Other Operating Activity | -662 | 1,239 | -33,210 | 6,460 | 0 |
| Operating Cash Flow | $2,921 | $-8,331 | $2,390 | $-1,680 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,042 | 7,836 | N/A | N/A | N/A |
| PPE Investments | -278 | -260 | 39,460 | -220 | N/A |
| Other Investing Activity | 0 | 0 | -8,920 | 0 | 0 |
| Investing Cash Flow | $-6,320 | $7,576 | $30,540 | $-220 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 155 | 75 | N/A | N/A | N/A |
| Other Financing Activity | -26,366 | 573 | -730 | 2,130 | 0 |
| Financing Cash Flow | $-26,212 | $648 | $-730 | $2,130 | $N/A |
| Exchange Rate Effect | 88 | 425 | 100 | 230 | N/A |
| Beginning Cash Position | 36,763 | 37,828 | 11,430 | 11,800 | N/A |
| End Cash Position | 7,242 | 38,146 | 43,740 | 12,260 | N/A |
| Net Cash Flow | $-29,522 | $317 | $32,300 | $450 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,921 | -8,331 | 2,390 | -1,680 | N/A |
| Capital Expenditure | -278 | -260 | N/A | N/A | N/A |
| Free Cash Flow | 2,643 | -8,591 | 2,390 | -1,680 | 0 |